(Press-News.org) Arlington, Va. — A new prototype for medicated chewing gum has been developed for motion sickness that may offer many advantages over conventional oral solid dosage forms. About 33 percent of people are susceptible to motion sickness in mild circumstances and 66 percent are affected in more severe conditions. This research is being presented at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition in Chicago, Ill., Oct. 14 – 18, an international event anticipating more than 8,000 attendees.
Lead researcher Mohsen Sadatrezaei of RoshaDarou Co. and a team of researchers consisting of Niloufar Pouyan, Zoherh JafariAzar and Alireza Ghaffari from the Islamic Azad University School of Pharmaceutical Sciences (Tehran, Iran), have developed a medicated gum that will improve patient compliance and faster absorption through the cheek, which will alleviate motion sickness sooner. A sensory panel was used to test faster absorption through the buccal cavity, which will result in earlier onset of action against motion sickness. Panelists also ranked the gum on bitterness and easiness to chew.
"The main challenge in delivering drugs through chewing gum is masking the bitter taste of its active ingredient," said Sadatrezaei. "We have formulated dimenhydrinate as chewing gum with acceptable taste and sensory attributes. Dimenhydrinate is among the best drug candidates for treatment of motion sickness, providing a comfortable and acceptable drug delivery."
The final formulation has great potential for dimenhydrinate chewing gum commercialization. Moreover, the outcome of the study can be used as a platform to incorporate other active ingredients with objectionable taste into chewing gum.
###The 2012 AAPS Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, aims to improve global health through advances in pharmaceutical sciences. The meeting features more than 90 programming sessions, including more than 50 symposia and roundtables.
AAPS is pleased to announce that our smartphone application is available at the 2012 AAPS Annual Meeting and Exposition. This application can assist meeting attendees with anything and everything they need to navigate the conference at their fingertips.
Editor's Note: All press must provide press credentials to attend this meeting. The deadline for online media registration is Oct. 5. After that date, media must register on-site. For media registration, please contact Kimberly Brown at BrownK@aaps.org or (703) 248-4772. To schedule an interview with Mohsen Sadatrezaei or for any other press inquiry, please contact Hillarie Turner or Dana Korsen at aaps@ecius.net or 202-296-2002.
About AAPS:
The American Association of Pharmaceutical Scientists is a professional, scientific society of approximately 11,000 members employed in academia, industry, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to serve the public and enhance their contributions to health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. For more information, please visit www.aaps.org. Follow us on Twitter @AAPSComms; official Twitter hashtag for the meeting is: #AAPS2012.
Novel chewing gum formulation helps prevent motion sickness
2012-10-17
ELSE PRESS RELEASES FROM THIS DATE:
Discovery of two opposite ways humans voluntarily forget unwanted memories
2012-10-17
If only there were a way to forget that humiliating faux pas at last night's dinner party. It turns out there's not one, but two opposite ways in which the brain allows us to voluntarily forget unwanted memories, according to a study published by Cell Press October 17 in the journal Neuron. The findings may explain how individuals can cope with undesirable experiences and could lead to the development of treatments to improve disorders of memory control.
"This study is the first demonstration of two distinct mechanisms that cause such forgetting: one by shutting down ...
Daily multivitamins reduce risk of cancer in men
2012-10-17
Boston, MA – A daily multivitamin can help a man reduce his risk of cancer, according to new research from Brigham and Women's Hospital (BWH). The first-of-its kind study will be presented October 17 at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research and published online the same day in the Journal of the American Medical Association.
"The Physicians' Health Study II is the first clinical trial to test the affects of multivitamins on a major disease such as cancer," said lead author J. Michael Gaziano, MD, chief of the Division ...
Daily sedation interruption for critically ill patients does not improve outcomes
2012-10-17
CHICAGO – For critically ill patients receiving mechanical ventilation, daily sedation interruption did not reduce the duration of mechanical ventilation or appear to offer any benefit to patients, and may have increased both sedation and analgesic use and nurse workload, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the European Society of Intensive Care Medicine Annual Congress.
"Critically ill patients wean more quickly from mechanical ventilation, with lower risk of delirium, when clinicians ...
Kaiser Permanente study finds efforts to establish exercise as a vital sign prove valid
2012-10-17
PASADENA, Calif., Oct. 17, 2012 — Kaiser Permanente has created a new electronic Exercise Vital Sign initiative to systematically record patients' physical activity in their electronic health records. The new feature is successfully compiling accurate and valuable information that can help clinicians better treat and counsel patients about their lifestyles, according to a Kaiser Permanente study published in the journal Medicine & Science in Sports & Exercise.
The study examined the electronic health records of 1,793,385 Kaiser Permanente Southern California patients ...
Multivitamin use among middle-aged, older men results in modest reduction in cancer
2012-10-17
CHICAGO – In a randomized trial that included nearly 15,000 male physicians, long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer after more than a decade of treatment and follow-up, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the Annual American Association for Cancer Research Frontiers in Cancer Prevention Research meeting.
"Multivitamins are the most common dietary supplement, regularly taken by at least one-third of U.S. adults. The traditional ...
UC Davis researchers clarify process controlling night vision
2012-10-17
On the road at night or on a tennis court at dusk, the eye can be deceived. Vision is not as sharp as in the light of day, and detecting a bicyclist on the road or a careening tennis ball can be tough.
New research reveals the key chemical process that corrects for potential visual errors in low-light conditions. Understanding this fundamental step could lead to new treatments for visual deficits, or might one day boost normal night vision to new levels.
Like the mirror of a telescope pointed toward the night sky, the eye's rod cells capture the energy of photons - ...
Extreme 'housework' cuts the life span of female Komodo dragons
2012-10-17
Extreme 'housework' cuts the life span of female Komodo Dragons
An international team of researchers has found that female Komodo Dragons live half as long as males on average, seemingly due to their physically demanding 'housework' such as building huge nests and guarding eggs for up to six months.
The results provide important information on the endangered lizards' growth rate, lifestyle and population differences, which may help plan conservation efforts.
The Komodo dragon is the world's largest lizard. Their formidable body size enables them to serve as top predators ...
Hard evidence grows for including meditation in government-sponsored health programs
2012-10-17
More people still die from cardiovascular disease than any other illness. Dubbed the number one killer and the silent killer, modern medicine has been researching and incorporating complementary and alternative approaches to help treat and in some cases reverse and hopefully prevent this health problem at an earlier stage of the disease. One of those modalities is meditation.
A new research review paper on the effects of the stress-reducing Transcendental Meditation (TM) technique on the prevention and treatment of heart disease among youth and adults provides the hard ...
The Internet of Things will transform our everyday
2012-10-17
Information technology and electronics are becoming entwined with our everyday lives in industry, the service sector, transport, logistics, health care, housing, education, and our leisure time, almost without our noticing it.
The changes are already apparent to consumers in the energy sector, for example: remotely readable meters are rapidly becoming more common, enabling developments such as new pricing models that encourage the reduction of carbon dioxide emissions. The remote control of machines and devices is experiencing substantial growth and spreading to smaller ...
Active surveillance provides a viable alternative to surgery for small kidney masses
2012-10-17
Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI.
The technique is primarily used to treat elderly patients who have complex health issues or decline surgery. But researchers from the Department of Urology at Churchill Hospital, Oxford, UK, say that the results of their study suggest that active surveillance could safely be extended to other selected patients.
"The incidence ...